DDI Study of Etravirine and GSK1265744

NCT00920296 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Infection, Human Immunodeficiency Virus

Interventions

DRUG: GSK1265744

Sponsor

GlaxoSmithKline